{
    "title": "Bristol Myers' Opdivo with Exelixis drug cuts kidney cancer death risk -study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8749351/Bristol-Myers-Opdivo-Exelixis-drug-cuts-kidney-cancer-death-risk-study.html",
    "date": "2020-09-18",
    "keywords": [
        "cancer",
        "combination",
        "drug",
        "opdivo",
        "kidney",
        "study",
        "oncology",
        "year",
        "york",
        "immunotherapy",
        "incs",
        "cabometyx",
        "risk",
        "death",
        "latestage",
        "length",
        "time",
        "survival",
        "chemotherapy",
        "pfizer",
        "brand",
        "name",
        "sutent",
        "doubt",
        "mind",
        "player",
        "treatment",
        "researcher",
        "dr",
        "choueiri",
        "danafarber",
        "institute",
        "boston",
        "community",
        "studys",
        "phase",
        "iii",
        "renal",
        "cell",
        "carcinoma",
        "part",
        "society",
        "meeting",
        "summary",
        "abstract",
        "safety",
        "side",
        "effect",
        "profile",
        "merck",
        "amp",
        "cos",
        "erman",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}